Logo Image
News
Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Media
Expert ConnectionsMorning RoundsThe VitalsPodcastsVideosBetween the LinesFrom All AnglesMeeting of the MindsShortsTraining Academy
Conferences
Conference CoverageConference Listing
Publications
More
CME/CE
Continuing Education
Resources
Case-Based Digest Rx Road MapEventsAdvanced Practice Corner
Partners

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Partners
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Gastrointestinal Cancer
    • Colorectal Cancer
    • Liver Cancer
    • Gastric Cancers
  • Genitourinary Cancer
    • Kidney Cancer
    • Bladder Cancer
    • Prostate Cancer
  • Gynecologic Cancers
    • Endometrial Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head and Neck Cancers
  • Hematology
    • Leukemia
    • Graft-Vs-Host Disease
    • Myeloproliferative Neoplasms
    • Multiple Myeloma
    • Lymphoma
  • Lung Cancer
  • Pediatric Cancer
  • Sarcomas
  • Skin Cancer
    • Melanoma
Advertisement

Alyson Moadel-Robblee, PhD

Advertisement

Articles by Alyson Moadel-Robblee, PhD

Alyson Moadel-Robblee on Barriers to Counseling for Patients with Prostate Cancer

ByAlyson Moadel-Robblee, PhD
March 10th 2017

Alyson Moadel-Robblee, PhD, discusses what keeps male patients with prostate cancer from seeking out counseling and therapy.

Advertisement

Latest Updated Articles

  • Alyson Moadel-Robblee on Barriers to Counseling for Patients with Prostate Cancer
    Alyson Moadel-Robblee on Barriers to Counseling for Patients with Prostate Cancer

    March 10th 2017



Advertisement
Advertisement

Trending on Oncology Nursing News

1

FDA Approves Gedatolisib for HR+/HER2- Advanced Breast Cancer: What Nurses Need to Know

2

FDA Approves Gedatolisib for HR+/HER2- Metastatic Breast Cancer

3

FDA Approves First On-Body Injector for Multiple Myeloma Treatment

4

FDA Grants Traditional Approval to Selpercatinib for RET-Fusion Solid Tumors

5

Multiple Myeloma Care: Innovative Nursing Strategies and Patient Support

  • About Us
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • CureToday.com
  • OncLive.com
  • TargetedOnc.com
  • Advertise
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us